Dr. Joshua Brody, MD @joshuabrodyMD Director, Lymphoma Immunotherapy Program Icahn School of Medicine at Mount Sinai gives an Update of Combining Immunotherapy with Targeted Therapies an Update from ASH 2015
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content